Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Tiziana Life Sciences PLC
TLSA | US
0.86
USD-0.01
-1.60%
TLSA | US
About Tiziana Life Sciences PLC
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/12/2023
As of date
21/10/2024
Close
0.86
Open
0.87
High
0.92
Low
0.83
Tiziana Life Sciences Ltd a biotechnology company focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401) a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's graft versus host ulcerative colitis multiple sclerosis type-1 diabetes inflammatory bowel psoriasis and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201) a small molecule inhibitor of various cyclin-dependent kinases tropomycin receptor kinases and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501) a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London the United Kingdom.Kingdom.
View LessTLSA | US
Risk
72.9
Sharpe
0.15
Luna's Score
34/100
Recommendation
Sell
Luna says (TLSA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
48.5%1 month
72.9%3 months
115.8%6 months
110.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
16.12
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-5.98
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-15.79M
MarketCap
87.80M
MarketCap(USD)
87.80M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-181.23
Short ratio
0.29
Short perc.
0.10
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.17
Range1M
0.27
Range3M
0.97
Volumes: Market Activity
Rel. volume
1.27
Price X volume
157.35K
